INDICATIONS
Adult rheumatoid arthritis (RA)
ORENCIA® is suitable for alleviating the symptoms and signs of adult patients with moderate to severe active rheumatoid arthritis, causing significant clinical reactions, inhibiting the progression of structural damage and improving physical function. In addition to tumor necrosis factor (TNF) antagonists, Pharmaceutical Consulting Company OERNCIA can also be used as a monotherapy or in conjunction with disease-modifying anti-rheumatic drugs (DMARD).
Juvenile idiopathic arthritis
ORENCIA is indicated for alleviating signs and symptoms of adolescent idiopathic arthritis with moderately to severely active polyarticular joints aged 2 years and older. ORENCIA can be used as a monotherapy or in combination with methotrexate (MTX).
Adult Psoriatic Arthritis (PsA)
ORENCIA is designated for the treatment of adult patients with active psoriatic arthritis (PsA).
Important usage restrictions
ORENCIA should not be used simultaneously with TNF antagonists. Named patient supply It is not recommended to use ORENCIA together with other biological rheumatoid arthritis (RA) treatments (such as anakinra).
No comments:
Post a Comment